In the present study, we demonstrated the close association of serum FGF21 concentrations with intrahepatic fat content in 138 patients with abnormal glucose metabolism and with B ultrasound-diagnosed hepatic steatosis, whose hepatic fat content were distributed in a large range (2.47%–81.95%). This evidence concerns the gene FGF21 and fatty liver disease.